Medicus Pharma (MDCX) Change in Cash (2024 - 2025)
Medicus Pharma's (MDCX) quarterly Change in Cash came in at $43127.0 in Q4 2025, up 103.78% YoY from $21163.8 in Q4 2024, and up 104.28% on a QoQ basis from -$1.0 million in Q3 2025.
Medicus Pharma (MDCX) Change in Cash (2024 - 2025) Analysis & Trends
Medicus Pharma (MDCX) has 2 years of Change in Cash data on file, last reported at $43127.0 in Q4 2025.
- Quarterly Change in Cash rose 103.78% year-over-year to $43127.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.5 million (up 85.72% YoY) and the FY2025 annual result came in at $4.5 million, up 85.72% from the prior year.
- Change in Cash advanced to $43127.0 in Q4 2025, from -$1.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $7.9 million in Q2 2024 to a low of -$3.1 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 1.49 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 739.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -4.45 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -727.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43,127.00 |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | 5.69 Mn |
| Mar 31, 2025 | -181,893.00 |
| Dec 31, 2024 | -1.14 Mn |
| Sep 30, 2024 | -3.10 Mn |
| Jun 30, 2024 | 7.87 Mn |
| Mar 31, 2024 | -1.18 Mn |